Article
Screening for new MTHFR polymorphisms and NTD risk.
American journal of medical genetics. Part A - 1 Oct 2005
O'Leary Valerie B, Mills James L, Parle-McDermott Anne, Pangilinan Faith, Molloy Anne M, Cox Christopher, Weiler Andrea, Conley Mary, Kirke Peadar N, Scott John M, Brody Lawrence C
Abstract excerpt
The enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a key role in cellular folate metabolism. The A222V (677C->T) polymorphism is a confirmed neural tube defect (NTD) risk factor within Irish and other populations. To search for other unknown single nucleotide polymorphisms (SNPs) that might play a role in the etiology of NTDs, we examined the entire MTHFR coding region in healthy individuals (n =...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
